Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Holger K. de Wolf"'
Autor:
Wytze P. Oosterhuis, Heleen van der Sijs, Albert J de Graaf, Wilhelmine P.H.G. Verboeket-van de Venne, Holger K. de Wolf, Jasmijn A. van Balveren, Ron Kusters, Rein M.J. Hoedemakers, Lale Erdem-Eraslan, Rolf J Verheul, Ruben E A Musson, Annemarieke E. Loot, Martin P. Schuijt
Publikováno v:
Diagnosis, 6(1), 69-71. De Gruyter
Background Knowledge of possible drug-laboratory test interactions (DLTIs) is important for the interpretation of laboratory test results. Test results may be affected by physiological or analytical drug effects. Failure to recognize these interactio
Autor:
Wim E. Hennink, Enrico Mastrobattista, Holger K. de Wolf, Cor J. Snel, Nina Johansson, Anh-Thy Thong, Gert Storm
Publikováno v:
Pharmaceutical Research
Purpose Tumor gene expression after the intravenous (i.v.) administration of current polymer-based gene delivery systems is generally low and short-lived. Immune stimulatory CpG dinucleotides, present within the plasmid DNA of the polyplexes are like
Autor:
Mies J. van Steenbergen, Wim E. Hennink, Gert Storm, Cor J. Snel, Holger K. de Wolf, Marcel H.A.M. Fens, Markus de Raad
Publikováno v:
Pharmaceutical Research
Purpose Previously, we have shown that complexes of plasmid DNA with the biodegradable polymer poly(2-dimethylamino ethylamino)phosphazene (p(DMAEA)-ppz) mediated tumor selective gene expression after intravenous administration in mice. In this study
Publikováno v:
Nanomedicine. 2:169-181
At present, there are no intravenously administered nucleic acid-based therapeutics that have been approved for human use. This reflects the difficulties in applying nucleic acid-based drugs: they are nuclease sensitive and have difficulties in reach
Publikováno v:
Journal of Controlled Release. 109:275-287
In recent years, increasing interest is being paid to the design of transfectants based on non-toxic and biodegradable polymers for gene therapy purposes. We recently reported on a novel, biodegradable polymer, poly(2-dimethylamino ethylamino)phospha
Publikováno v:
Clinica Chimica Acta. 412:1683-1685
Background Carbohydrate-deficient transferrin (CDT) is used as a marker for chronic alcohol abuse. The presence of genetic transferrin variants might affect an individual's iron status and can interfere with CDT analysis. We report on the identificat
Autor:
C. Lin, Jan Feijen, Martin C. Lok, Zhiyuan Zhong, W.E. Hennink, Holger K. de Wolf, Johannes F.J. Engbersen
Publikováno v:
ISSUE=10;STARTPAGE=94;ENDPAGE=97;TITLE=10th European Symposium on Controlled Drug Delivery, ESCDD 2008
Journal of controlled release, 132(3), e9-e10. Elsevier
Journal of controlled release, 132(3), e9-e10. Elsevier
Bioreducible poly(amido amine)s (SS-PAAs) with different groups in the side chain were evaluated for gene delivery to ovarian cancer cells, both in vitro and in vivo after intraperitoneal administration in mice bearing an ovarian cancer xenograft. Po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98998ee8d21126bacd0cdab4dd14f882
https://research.utwente.nl/en/publications/bioreducible-polyamido-amines-for-gene-delivery-to-ovarian-cancer-cells(3f51e78a-fc18-4ec5-b44a-3d6014c974b0).html
https://research.utwente.nl/en/publications/bioreducible-polyamido-amines-for-gene-delivery-to-ovarian-cancer-cells(3f51e78a-fc18-4ec5-b44a-3d6014c974b0).html
Publikováno v:
Molecular pharmaceutics. 5(2)
A series of cationic, methacrylamide polymers was tested for use as a biodegradable gene carrier in ovarian cancer. Tumor transfection activity of polyplexes consisting of a reporter gene and different methacrylamide polymers was assessed, after intr
Autor:
Raymond M. Schiffelers, Wim E. Hennink, Cor J. Snel, Gert Storm, Holger K. de Wolf, F.J. Verbaan
Publikováno v:
International journal of pharmaceutics. 331(2)
Nucleic acid based therapeutics are currently being studied for their application in cancer therapy. In this study, the effect of different cationic delivery systems on the circulation kinetics, tumor localization, and tissue distribution of short in
Comparison of a New Procalcitonin Assay from Roche with the Established Method on the Brahms Kryptor
Autor:
Jody M.W. van den Ouweland, Holger K. de Wolf, Jacqueline M. T. Klein Gunnewiek, Yvonne Berk, Menno de Metz
Publikováno v:
Clinical Chemistry. 55:1043-1044
Procalcitonin (PCT) is a 13-kDa peptide and a precursor of calcitonin. In a healthy population, PCT concentrations are negligible (1). In systemic bacterial and fungal infections, plasma concentrations are raised, whereas concentrations remain fairly